Day and colleagues were the first group to use a series of modifications to the C-terminal portion of the glucagon sequence to increase GLP-1R potency, combined with PEGylation to generate two PEGylated peptides with adequate co-agonist properties, one unbalanced towards GLP-1R, and the other a near-balanced agonist at both GLP-1R and GCGR
This need challenges us to understand how a precursor cell gives rise to the pancreas and to characterize the gene products that specify cell fates during organogenesis
But "longevity peptides" is a loose label that groups together compounds working through completely different mechanisms NAD+ metabolism, telomere biology, mitochondrial signaling, and gene expression
Preitner F, Ibberson M, Franklin I, et al
Orforglipron delivers superior weight loss outcomes with a weekly dosing schedule and an improved side-effect profile
These individuals may require proactive management strategies and potentially slower titration schedules
